Why Is Abbott Stock Trading Higher On Thursday?

On Wednesday, Abbott Laboratories ABT reported fourth-quarter sales of $10.97 billion, up 7.2$11.01 billion.Organic sales growth for the underlying base business was 8.8%. Organic growth, excluding COVID-19 testing-related sales was 10.1%.Stifel analyst Rick Wise has a positive outlook on Abbott’s Q4 2024 results and its 2025 projections. He sees strong momentum in the Diabetes Care and Structural Heart segments, which are expected to drive double-digit growth in t ...